Abstract:http://www.esciencecentral.org/journals/aging-science-abstract.phpSenescence is characterized by the decline in the ability to cope with stress. Hormesis regulation of opposing biological effects of low and high dosages, can determine longevity, and disease vulnerability at appropriate doses. Regulation of age-related changes in micro RNA opens new areas of therapeutic targets. Micro RNA downregulates stress response pathways with age establishing vulnerability to multiple age related disease which, if targeted could theoretically delay senescence. Mitochondrial targeted drugs have intervened in seemingly otherwise unrelated pathologies like neurological diseases, Alzheimer’s disease, infections, diabetes, acute ischemic shock, and wound healing; an example of a common magic bullet for intervention in mitochondrial dysfunction pathologies of oxidative stress. The telomerase subunit, TERT, the promiscuous reverse transcriptase, exhibits hormetic activity, benefit at low levels, dysfunctional at high levels, and is required for signally survival. The appropriate targeted telomerase therapy is key for optimal desired drug therapy for inhibition in cancer and HIV infected therapy and enhanced in bystander cells for oxidative stress tolerance. Comparative biology studies reveal the role of Neuregulin and Nrf2, as key players in the puzzle of the long lived disease free mole rat despite high levels of oxidative stress. A hibernation stress response cold shock peptide restores synaptic plasticity, and is beneficial in neurodegeneration. Muscles and gut are not only responsible for their respective roles in locomotion and digestion but also regulate systemic responses in the body. New insights into the roles of muscles and gut change how drugs affect multiple organs and impact the route of administration. While oxidative stress can either signal metabolic benefits, death or be neutralized by a wheelhouse of antioxidant pathways, recent technological advances and conceptual shifts, allow regulation of opposing consequences by appropriate targeting of drugs to achieve protective effects in multiple age related diseases.

Role of Physiological Resilience in Aging: Challenges and Opportunities

Negative Effects of Lifespan Extending Intervention on Resilience in Mice.

Using Physiological System Networks to Elaborate Resilience Across Frailty States

CLARIFYING THE ROLE OF RESILIENCE IN NONHUMAN PRIMATE AGING USING A BABOON CELL MODEL

Biological resilience in health and disease

Stress-induced biological aging: A review and guide for research priorities

Longitudinal Fragility Phenotyping Predicts Lifespan and Age-Associated Morbidity in C57BL/6 and Diversity Outbred Mice

Longitudinal fragility phenotyping contributes to the prediction of lifespan and age-associated morbidity in C57BL/6 and Diversity Outbred mice

Perspective: Modulating the integrated stress response to slow aging and ameliorate age-related pathology

Modulating the integrated stress response to slow aging and ameliorate age-related pathology

Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age

New Discoveries Alter the Landscape Potential of Anti-Aging Therapy

Biology of healthy aging: Biological hallmarks of stress resistance-related and unrelated to longevity in humans

Experimental variables that impact outcomes in aging stress response

Quantification of healthspan in aging mice: Introducing FAMY and GRAIL

Comparison of Age-Related Decline and Behavioral Validity in C57BL/6 and CB6F1 Mice

The stress of aging

[Age-related resilience as a manifestation of neurovegetative regulation of organism's functions]

Differential Responses of Dynamic and Entropic Aging Factors to Longevity Interventions

Essential Physiological Differences Characterize Short- and Long-Lived Strains of Drosophila melanogaster

Data integration in systems genetics and aging research